| Previous Close | 35.4500 |
| Open | 35.9300 |
| Bid | 35.9200 x 6900 |
| Ask | 35.9300 x 3300 |
| Day's Range | 35.8200 - 36.2100 |
| 52 Week Range | 29.8300 - 36.2100 |
| Volume | 9,598,678 |
| Avg. Volume | 17,372,446 |
| Market Cap | 214.05B |
| Beta | 1.06 |
| PE Ratio (TTM) | 26.33 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.28 (3.62%) |
| Ex-Dividend Date | 2017-08-02 |
| 1y Target Est | N/A |
Reuters•1 hour agoPfizer files suit against J&J over Remicade contracts
Pfizer said that J&J signed contracts with U.S. health insurers that required patients to "fail first" on Remicade before they considered competitors such as Pfizer's biosimilar, a rival drug that regulators approved as a generic substitute. The contract was required in order for insurers to receive after-market rebates and effectively prevented hospitals and doctors from stocking the biosimilar, Pfizer said.
- Zacks•2 hours ago
Pfizer's Sutent Label Expansion Gets Mixed FDA Committee View
Pfizer's (PFE) cancer drug Sutent gets a mixed opinion from an FDA advisory committee regarding a regulatory application, which was filed to expand its label.
- Reuters•2 hours ago
US STOCKS-Wall St opens little changed; Fed takes center stage
Wall Street opened little changed on Wednesday as investors waited for the conclusion of the two-day Federal Reserve meeting for indications of a third interest rate hike this year. Fed Chair Janet Yellen will hold a press conference half an hour later, which will be closely watched for views on inflation.
